First Bancshares Upgraded by Zacks Investment Research

First Bancshares has 3 insider buys in recent days after announcing the purchase of Alabama Bank. Zacks upgraded the stock to a Buy rating today.

First Bancshares stock was upgraded by analysts at Zacks Investment Research from a Hold rating to a Buy rating. They now have a $35 price target on the stock which represents 9.7% upside from the previous close of $31.90.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

AMN Healthcare Services Pocket Pivot and Rising Large Players Volume

Strong technical setup with bullish sentiment from analysts. The company is also a strong seasonal play. The company was also recently ranked #11 on Fortune’s 100 Fastest Growing Companies list.

AMN Healthcare Services chart shows a beautiful setup with rising large players volume and a pocket pivot signal.

AMN Healthcare Services is also a good seasonal play. Over the next 10 weeks, AMN Healthcare Services has on average historically risen by 9.4% based on the past 15 years of stock performance. AMN Healthcare Services has risen higher in 12 of those 15 years over the next 10 week period, corresponding to a historical probability of 80%.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Intevac Company Consolidating On Rising Large Players Volume

Intevac Inc stock is consolidating as large players volume moves higher after the company reported revenue growth of 18% year-over year.

Intevac issued its earnings results on Monday, October, 30th. The company reported EPS of $0.04 for the quarter. The company beat on revenue of $26.70 million versus analysts estimates of $25.50 million.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Ur-Energy Company Gets 277 Percent Price Target From Roth Capital

Ur-Energy was given a new $2 price target by analysts at Roth Capital which represents 277.4% upside from the current price. Roth Capital has a Buy rating on the stock.

Ur-Energy has 3 Buy ratings with a consensus price target of $1.67 which represents 214.47% upside from the current price.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Verastem Price Target Set 364 Percent Higher By Cantor Fitzgerald

Verastem stock had a price target set 364% higher than its current price by Cantor Fitzgerald. Cantor Fitzgerald has a buy rating on the stock.

Verastem is on track for duvelisib NDA in Q1 2018, to include accelerated approval request for follicular lymphoma. Duvelisib is a dual inhibitor of two enzymes called phosphoinositide 3-kinase (PI3K)-delta and PI3K-gamma. Both are associated with the growth and survival of malignant B cells and T cells.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

TrueBlue Company Beats as Large Players Volume Surges

TrueBlue Company beat on earnings and revenue. The company reported Q3 EPS of $0.60 versus the estimate of $0.58. Revenue also beat coming in at $660.78 million for the quarter versus the estimate of $651.91 million.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Archrock Partners Exploding Large Players Volume On Analyst Buy Rating

Archrock Partners large players volume has exploded higher as price has moved lower. This is a huge positive divergence and very bullish for the stock.

Royal Bank Of Canada reiterated its Buy rating on Archrock Partners stock and set a price target of $19 which represents 44.27% upside from the current price. I'm seeing a lot of bullish analysts actions in many oil and gas stocks.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

Incyte Corporation Rising Large Players Volume in Ascending Triangle

Incyte Corporation stock has rising large players volume in an Ascending Triangle pattern. The large players volume rising while Incyte has been consolidating is a bullish pattern.

TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

S&P Retail SPDR Market Prediction Path Moved Lower

The S&P Retail ETF XRT was revised lower today on the Symmetrical Triangle breakdown. XRT broke down out of the Symmetrical Triangle pattern after J.C. Penny cut its 2017 earnings forecast on Friday, October 27, 2017. J.C. Penney cut its forecast for 2017 adjusted earnings to 2 cents to 8 cents per share from 40 cents to 65 cents. The breakdown today on XRT wasn’t just about J.C. Penny. Citigroup downgraded Macy’s stock from “Neutral” to “Sell” on Monday, October 30, 2017, citing poor performance from the company’s retail business as the primary reason. Citi analyst Paul Lejuez said that Macy’s has seen significant pressure on sales/margins for several years, and that they no longer make much money as a retailer.
Continue reading “S&P Retail SPDR Market Prediction Path Moved Lower”